India to Canada: Oseltamivir Export Trade Route

The India to Canada Oseltamivir corridor is one of India's established pharmaceutical export routes, with 93 shipments documented worth a combined $13.0M USD. The route is dominated by NATCO PHARMA LIMITED, which alone accounts for roughly 58% of all export value, reflecting the consolidated nature of India's oseltamivir manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $139.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with oseltamivir's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 33.9%, placing it at rank #4 among India's top oseltamivir export destinations globally.

On the import side, key buyers of Indian oseltamivir in Canada include NATCO PHARMA (CANADA) INC, NATCO PHARMA (CANADA) INC , NATCO PHARMA CANADA INC and 7 others. NATCO PHARMA (CANADA) INC is the single largest importer with 39 shipments valued at $5.9M USD.

India's oseltamivir exports to Canada are driven primarily by a handful of large-scale manufacturers. NATCO PHARMA LIMITED with 47 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NATCO PHARMA LIMITED, NATCO PHARMA LIMITED , STRIDES PHARMA SCIENCE LIMITED — together account for 98% of total trade value on this route. The average shipment value of $139.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as nat-oseltamivir phosphate 75 mg capsules and nat-oseltamivir 30mg capsules 10's (206496x10's)(appendix 4r, rodtep entry no:10153)(other reference(s) ci no: 123282), suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NATCO PHARMA (CANADA) INC is the largest importer with 39 shipments worth $5.9M USD — representing 45% of all oseltamivir imports from India on this route. A total of 10 buyers are active on this corridor.